Group 1 - The controlling shareholder, Inner Mongolia Jinhe Holdings Co., Ltd., plans to reduce its shareholding by up to 22,563,389 shares, representing 3% of the company's total share capital, from June 10, 2025, to September 9, 2025 [2] - As of August 11, 2025, Jinhe Holdings has already reduced its holdings by 5,065,000 shares, bringing its total shareholding to 273,679,052 shares, which is 36.3880% of the company's total share capital after excluding shares in the repurchase account [2][6] - The total share capital for calculation purposes is 752,112,988 shares, after excluding 19,521,410 shares in the company's repurchase account [2] Group 2 - The company has recently obtained an invention patent and a design patent from the National Intellectual Property Administration [5] - The invention patent relates to a microbial fermentation plant with a circular distribution of fermentation tanks, optimizing space utilization and energy consumption in the company's sixth-phase fermentation workshop [6] - The design patent protects the visual appearance of the microbial fermentation plant, enhancing the company's industrial architectural image [6][7]

2025年1至6月份，金河生物的营业收入构成为：兽用化学药品占比61.83%，农产品加工业占比 19.76%，兽用生物制品占比11.12%，环保业务占比4.97%，其他占比2.15%。 （文章来源：每日经济新闻） 金河生物（SZ 002688，收盘价：7.69元）8月12日晚间发布公告称，公司于近日获得由国家知识产权局 颁发的发明专利及外观设计专利证书。专利名称为"罐体圆周分布的微生物发酵厂房"。 ...